Regeneron drug proves effective in preventing COVID

Regeneron is pursuing U.S. approval for its COVID-19 antibody cocktail as a preventative treatment after it helped cut the risk of symptomatic infections in households where someone else is ill, the U.S. drugmaker said on Monday. Colette Luke has more.